Astonea Labs Ltd vs Influx Healthtech Ltd Stock Comparison
Astonea Labs Ltd vs Influx Healthtech Ltd Stock Comparison
Last Updated on: Jun 14, 2026
Key Highlights
The Latest Trading Price of Astonea Labs Ltd is ₹ 243.7 as of 12 Jun 15:30
. The P/E Ratio of Astonea Labs Ltd changed from 0 on March 2022 to 0 on March 2021 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2022 to 0 on March 2021 . This represents a CAGR of 0.0% over 5 years The Market Cap of Astonea Labs Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2022 to 0 % on March 2021 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2022 to 0 % on March 2021 . This represents a CAGR of 0.0% over 5 years .
About Astonea Labs Ltd
Astonea Labs Limited was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
Subsequently, the Company further changed the name to 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024.
Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.
About Influx Healthtech Ltd
Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai.
Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.
FAQs for the comparison of Astonea Labs Ltd and Influx Healthtech Ltd
Which company has a larger market capitalization, Astonea Labs Ltd or Influx Healthtech Ltd?
Market cap of Astonea Labs Ltd is 256 Cr while Market cap of Influx Healthtech Ltd is 551 Cr
What are the key factors driving the stock performance of Astonea Labs Ltd and Influx Healthtech Ltd?
The stock performance of Astonea Labs Ltd and Influx Healthtech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Astonea Labs Ltd and Influx Healthtech Ltd?
As of June 14, 2026, the Astonea Labs Ltd stock price is INR ₹243.7. On the other hand, Influx Healthtech Ltd stock price is INR ₹238.15.
How do dividend payouts of Astonea Labs Ltd and Influx Healthtech Ltd compare?
To compare the dividend payouts of Astonea Labs Ltd and Influx Healthtech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.